An interaction between growth hormone/insulin-like growth factor-1 and vitamin D in children with short stature

Authors

DOI:

https://doi.org/10.18370/2309-4117.2022.63.34-38

Keywords:

short stature, children, growth hormone, insulin-like growth factor-1, 25-hydroxycalciferol

Abstract

There are disorders in the growth hormone (GH)/growth factors system in a significant part of patients with short stature; first of all, this concerns such diseases as growth hormone deficiency, where there is a sharp decrease in GH, insulin-like growth factor-1 (IGF-1). The association between vitamin D and GH/growth factor system remains unclear. It was found that vitamin D is able to increase IGF-1 level in healthy individuals. Linear growth is accelerated after treatment of vitamin D deficiency in children, which may indicate the linking role of vitamin D between the proliferative cells of the growth plate cartilage and GH/growth factor system.
Research objective: to determine 25-hydroxyvitamin D level in blood plasma in children with short stature, depending on the state of GH/IGF-1 system.
Materials and methods. Study included 101 children with short stature: 33 children with partial somatotropic insufficiency (group 1); 44 children with complete somatotropic insufficiency (group 2); 24 children with syndrome of biologically inactive GH (group 3). Patients in groups 1 and 2 had a confirmed GH deficiency and a decrease or sharp decrease in of IGF-1 level; patients in group 3 had a normal stimulated release of GH against the background of a reduced IGF-1 level. GH, IGF-1, 25-hydroxyvitamin D, thyroid-stimulating hormone, and free thyroxine were determined in all children.
Results. The average level of vitamin D in three groups corresponded to the vitamin deficiency according to international standards and was 52.24 ± 5.99 nmol/l in patients with partial somatotropic insufficiency, 67.6 ± 5.35 nmol/l in patients with complete somatotropic insufficiency and 58, ± 7.91 nmol/l in patients with syndrome of biologically inactive GH. A direct correlation was found between vitamin D and background GH level, stimulated GH level in children with both partial and complete somatotropic insufficiency. A direct correlation between vitamin D and IGF-1 level in this group of patients was also detected.
Conclusions. It is advisable to determine the serum 25(OH)D in all children with short stature. Vitamin D levels should be taken into account in insulin/clonidine diagnostic tests in order to obtain a realistic indication of stimulated GH and IGF-1 levels.

Author Biographies

O.V. Bolshova, SI “V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine”, Kyiv

MD, professor, head of the Branch of Pediatric Endocrine Pathology

N.A. Sprynchuk, SI “V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine”, Kyiv

MD, professor, Department of Endocrinology, head of the Department of Pediatric Endocrine Pathology

D.A. Kvacheniuk, SI “V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine”, Kyiv

Paediatric endocrinologist, Department of Pediatric Endocrine Pathology

N.M. Muz, SI “V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine”, Kyiv

PhD, paediatric endocrinologist, Department of Pediatric Endocrine Pathology

M.O. Ryznychuk, Bukovinian State Medical University, Chernivtsi

PhD, associate professor, Department of Pediatrics and Medical Genetics

I.V. Lukashuk, SI “V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine”, Kyiv

PhD, researcher, Branch of Pediatric Endocrine Pathology

T.M. Malinovska, SI “V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine”, Kyiv

PhD, senior researcher, Branch of Pediatric Endocrine Pathology

O.Y. Samson, SI “V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine”, Kyiv

PhD, senior researcher, Branch of Pediatric Endocrine Pathology

O.A. Vyshnevska, SI “V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine”, Kyiv

PhD, senior researcher, Branch of Pediatric Endocrine Pathology

V.H. Pakhomova, SI “V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine”, Kyiv

PhD, paediatric endocrinologist, Department of Pediatric Endocrine Pathology

References

  1. Savage, M.O., Burren, C.P., Rosenfeld, R.G. “The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challenges.” Clin Endocrinol (Oxf) 72.6 (2010): 721–8. DOI: 10.1111/j.1365-2265.2009.03775.x
  2. Rosenfeld, R.G. “Endocrinology of growth.” Nestle Nutr Workshop Ser Pediatr Program 65 (2010): 225–34. DOI: 10.1159/000281170
  3. Fernández-Cancio, M., Audi, L., Carrascosa, A. “Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal epiphyseal chondrocytes.” Growth Horm IGF Res 19.3 (2009): 232–7. DOI: 10.1016/j.ghir.2008.10.004
  4. Murray, P.G., Clayton, P.E. “Endocrine control of growth.” Am J Med Genet C Semin Med Genet 163C.2 (2013): 76–85. DOI: 10.1002/ajmg.c.31357
  5. Martinelli, C.E., Custódio, R.J., Aguiar-Oliveira, M.H. “Physiology of the GH-IGF axis.” Arq Bras Endocrinol Metabol 52.5 (2008): 717–25. DOI: 10.1590/s0004-27302008000500002
  6. Holick, M.F. “The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention.” Rev Endocr Metab Disord 18.2 (2017): 153–65. DOI: 10.1007/s11154-017-9424-1
  7. Lips, P. “Vitamin D physiology.” Prog Biophys Mol Biol 92.1 (2006): 4–8. DOI: 10.1016/j.pbiomolbio.2006.02.016
  8. Sahin, O.N., Serdar, M., Serteser, M. “Vitamin D levels and parathyroid hormone variations of children living in a subtropical climate: a data mining study.” Ital J Pediatr 44.1 (2018): 40. DOI: 10.1186/s13052-018-0479-8
  9. Gannagé-Yared, M.H., Sabbagh, R., Chédid, R. “Relationship between 25 hydroxyvitamin D and lipid profile in Lebanese school children.” J Endocrinol Invest 41.9 (2018): 1043–9. DOI: 10.1007/s40618-018-0840-1
  10. Shin, Y.H., Shin, H.J., Lee, Y.J. “Vitamin D status and childhood health.” Korean J Pediatr 56.10 (2013): 417–23. DOI: 10.3345/kjp.2013.56.10.417
  11. Lukyanova, O.M., Antypkin, Y.G., Omelchenko, L.I., Kvashnina, O.V. “Theoretical and practical issues of classification, prevention and treatment of rickets in children at the present stage.” Pediatr, obstetr and gynecol 4 (2008): 11–2.
  12. Kvashnina, O.V., Rodionov, V.P., Makovkina, Y.A., Oniskova, O.V. “The effect of vitamin D-deficiency on the physical performance of children of primary school age.” Perinatol and pediatr 2 (2011): 46–8.
  13. Maidannyk, V.G., Demchuk, S.M. “Modern approaches to the prevention and treatment of vitamin D-deficient rickets from the standpoint of evidence-based medicine.” 8.2 (2015): 133–43.
  14. Pankiv, V.I., Povorozniuk, V.V., Pashkovska, N.V., et al. “Vitamin D status of an outpatient population attending the endocrinology center.” Nutrition and metabolism 5 (2021): 204.
  15. Beketova, G.V., Povorozniuk, V.V., Syvachenko, Y.V., et al. “Influence of age, gender, sexual development and seasonality at 25(OH)D level in schoolchildren of Kyiv city.” Nutrition and metabolism 5 (2021): 56.
  16. Povorozniuk, V.V., Beketova, G.V., Klymova, Y.V., et al. “25(OH)D level, deficiency and insufficiency in the Kyiv city schoolchildren.” World of Medicine and Biology 17.75 (2020): 135–8.
  17. Ncayiyana, J.R., Martinez, L., Goddard, E., et al. “Prevalence and Correlates of Vitamin D Deficiency among Young South African Infants: A Birth Cohort Study.” Nutrients 13.5 (2021): 1500. DOI: 10.3390/nu13051500
  18. Gannagé-Yared, M.H., Chahine, E., Farah, V., et al. “Serum insulin-like groeth factor 1 in Lebanese schoolchildren and its relation to vitamin D and ferritin levels.” Endocr Pract 23.4 (2017): 391–8. DOI: 10.4158/EP161623.OR
  19. Morris, H.A., Anderson, P.H. “Autocrine and paracrine actions of vitamin D.”Clin Biochem Rev 31.4 (2010): 129–38.
  20. Ameri, P., Giusti, A., Boschetti, M. “Interactions between vitamin D and IGF-I: from physiology to clinical practice.” Clin Endocrinol (Oxf) 79.4 (2013): 457–63. DOI: 10.1111/cen.12268
  21. Ciresi, A., Cicciò, F., Giordano, C. “High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment.” J Endocrinol Invest 37.7 (2014): 631–8. DOI: 10.1007/s40618-014-0084-7
  22. Hamza, R.T., Hamed, A.I., Sallam, M.T. “Vitamin D status in prepubertal children with isolated idiopathic growth hormone deficiency: effect of growth hormone therapy.” J Investig Med 66.5 (2018): 1–8. DOI: 10.1136/jim-2017-000618
  23. Ciresi, A., Giordano, C. “Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess.” Growth Horm IGF Res 33 (2017): 35–42. DOI: 10.1016/j.ghir.2017.02.002
  24. Jawa, A., Riaz, S.H., Khan Assir, M.Z. “Causes of short stature in Pakistani children found at an Endocrine Center.” Pak J Med Sci 32.6 (2016): 1321–5. DOI: 10.12669/pjms.326.11077
  25. Durá-Travé, T., Gallinas-Victoriano, F., Moreno-González, P.“Vitamin D status and response to growth hormone treatment in prepubertal children with growth hormone deficiency.” J Endocrinol Invest 43.10 (2020): 1485–92. DOI: 10.1007/s40618-020-01227-3
  26. Ranke, M.B. “Diagnosis of growth hormone deficiency and growth hormone stimulation tests. Diagnostics of endocrine function in children and adolescents.” Basel, Karger 4 (2003): 107–28. DOI: 10.1159/000073547
  27. Bischoff-Ferrari, H.A., Giovannucci, E., Willett, W.C., et al. “Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.” Am J Clin Nutr 84 (2006): 18–28.
  28. Gómez de Tejada Romero, M.J., Sosa Henríquez, M., Del Pino Montes, J., et al. “Position document on the requirements and optimum levels of vitamin D.” Rev Osteoporos Metab Miner 3.1 (2011): 53–64.
  29. World Health Organization. The WHO Child Growth Standards. World Health Organization classification of stunting among children (2007). Available from: [https://www.who.int/childgrowth/en/].
  30. Greulich, W.W., Pyle, S.I. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. USA: Pyle Stanford University Press (1993): 256 p.
  31. Tanner, J.M., Davies, P.S. “Clinical longitudinal standards for height and height velocity for north American children.” J Pediatr 107.3 (1985): 317–29.
  32. Hamza, R.T., Hamed, A.I., Sallam, M.T. “Vitamin D status in prepubertal children with isolated idiopathic growth hormone deficiency: effect of growth hormone therapy.” J Investig Med 66.5 (2018): 1–8. DOI: 10.1136/jim-2017-000618
  33. Ameri, P., Giusti, A., Boschetti, M. “Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency.” Eur J Endocrinol 169.6 (2013): 767–72. DOI: 10.1530/EJE-13-0510
  34. Bolshova, O.V., Muz, N.M., Kvacheniuk, D.A., Ryznychuk, M.O. “Vitamin D levels in children with short stature due to small for gestational age on the background of normosomatotropinemia.” Internat endocrinol J 16.2 (2020): 104–10.

Downloads

Published

2022-05-27

How to Cite

Bolshova, O., Sprynchuk, N., Kvacheniuk, D., Muz, N., Ryznychuk, M., Lukashuk, I., Malinovska, T., Samson, O., Vyshnevska, O., & Pakhomova, V. (2022). An interaction between growth hormone/insulin-like growth factor-1 and vitamin D in children with short stature. REPRODUCTIVE ENDOCRINOLOGY, (63-64), 34–38. https://doi.org/10.18370/2309-4117.2022.63.34-38

Issue

No. 63-64 (2022)

Section

Endocrinology

License

Copyright (c) 2022 О.В. Большова, Н.А. Спринчук, Д.А. Кваченюк, Н.М. Музь, М.О. Ризничук, І.В. Лукашук, Т.М. Маліновська, О.Я. Самсон, О.А. Вишневська, В.Г. Пахомова

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.